Showing results (811-820 of 1,494) with videos related to

Sort By:
Pageof 150
British Journal of Cancer|October 2, 2003
A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinomaA R Clamp, F H Blackhall, P Vasey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Forearm blood flow and local responses to peptide vasodilators: a novel pharmacodynamic measure in the phase I trial of antagonist G, a neuropeptide growth factor antagonistS Clive, D J Webb, A MacLellan, et al.
British Journal of Cancer|January 1, 1997
A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancerN Siddiqui, A V Boddy, H D Thomas, et al.
Experimental Physiology|May 12, 2009
A novel dephosphorylation-activated conductance in a mouse renal collecting duct cell lineS Laycock, H C Taylor, C Haigh, et al.
Nucleus (Austin, Tex.)|October 11, 2011
The role of Lamin A in cytoskeleton organization in colorectal cancer cells: a proteomic investigationClare R Foster, Joanne L Robson, William J Simon, et al.
Stem Cells and Development|April 26, 2022
Modulation of PKM1/2 Levels by Steric Blocking Morpholinos Alters the Metabolic and Pluripotent State of Murine Pluripotent Stem CellsJoshua G Dierolf, Hailey L M Hunter, Andrew J Watson, et al.
Archives of Pediatrics & Adolescent Medicine|September 11, 1999
Maternal disciplinary practices in an at-risk populationR R Socolar, J Winsor, W M Hunter, et al.
The Journal of Animal Ecology|September 17, 2009
Survival and breeding of polar bears in the southern Beaufort Sea in relation to sea iceEric V Regehr, Christine M Hunter, Hal Caswell, et al.
Domestic Animal Endocrinology|October 11, 2003
Attenuation of PGF2alpha release in ewes infused with the oxytocin antagonist L-368,899G E Mann, G E Lamming, D Scholey, et al.
Pageof 150